✦ LIBER ✦

Clinical pharmacologic investigations with carvedilol, a new beta-blocker with direct vasodilator activity

✍ Scribed by Möllendorff, Erika v; Abshagen, Ulrich; Akpan, Waltraud; Neugebauer, Günter; Schröter, Eva

Book ID: 109843868
Publisher: Nature Publishing Group
Year: 1986
Tongue: English
Weight: 491 KB
Volume: 39
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.1986.118

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacological profile of ?-adrenocepto

Pharmacological profile of ?-adrenoceptor blockers with vasodilating properties, especially carvedilol ? rationale for clinical use

✍ Sponer, G. ;Bartsch, W. ;Strem, K. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 750 KB

The rationale for the combined use of beta-adrenoceptor antagonists and vasodilators is to improve the efficacy of the antihypertensive therapy and to reduce the incidence of side effects. If suitable coagents are selected and used at appropriate doses, the disadvantages of each separate component (

Carvedilol, a new nonselective beta-bloc

Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis

✍ Rafael Bañares; Eduardo Moitinho; Belén Piqueras; Marta Casado; Juan-Carlos Garc 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Evaluation of celiprolol, a new cardiose

Evaluation of celiprolol, a new cardioselective beta1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly

✍ K. D. Lamon 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 499 KB

Celiprolol hydrochloride is a cardioselective beta 1-adrenergic antagonist with partial agonist activity. The studies discussed were designed to assess celiprolol's pharmacokinetic disposition, its efficacy versus placebo and other beta blockers, its relative safety profile, and its therapeutic rati